A federal judge overseeing hundreds lawsuits by women who claim the anti-nausea drug Zofran causes birth defects and that GlaxoSmithKline PLC failed to warn of its risks on Wednesday said the first trial nationally would take place in January.

U.S. District Judge F. Dennis Saylor in Boston set the Jan. 13 date for the bellwether case after previously pushing back what was to be a September trial so he could hear new arguments about whether federal law preempts the women’s state law claims.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2Z18Wb3


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s